High Risk Neuroblastoma

specific

Neuroblastoma usually presenting with metastatic disease and MYCN gene amplifications.

41

Centers

48

Active Trials

$569K

Cancer Funding

Top Centers for High Risk Neuroblastoma(41)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.7
2
NCI Comprehensive
High-Volume Research Center
71.1
3
High-Volume Research Center
71.1
4
NCI Comprehensive
Active Research Program
68.9
5
Active Research Program
68.9
6
NCI Comprehensive
Active Research Program
49.1
7
NCI Comprehensive
Active Research Program
49.1
8
NCI Comprehensive
Active Research Program
49.1
9
NCI Comprehensive
Active Research Program
49.1
10
NCI Comprehensive
Active Research Program
49.1
11
NCI Comprehensive
Active Research Program
49.1
12
NCI Comprehensive
Active Research Program
49.1
13
NCI Comprehensive
Active Research Program
49.1
14
NCI Comprehensive
Active Research Program
49.1
1549.1
16
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
49.1
17
NCI Comprehensive
Active Research Program
49.1
18
NCI Comprehensive
Active Research Program
49.1
19
NCI Comprehensive
Active Research Program
49.1
20
NCI Comprehensive
Active Research Program
49.1
21
NCI Clinical
Active Research Program
49.1
22
Active Research Program
49.1
23
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
49.1
24
Active Research Program
49.1
25
NCI Comprehensive
Active Research Program
49.1
26
NCI Clinical
Active Research Program
49.1
27
NCI Comprehensive
Active Research Program
49.1
28
NCI Clinical
Active Research Program
49.1
29
Active Research Program
49.1
30
NCI Comprehensive
Active Research Program
49.1
3149.1
32
Active Research Program
49.1
33
Active Research Program
49.1
34
Active Research Program
49.1
35
Active Research Program
49.1
36
Active Research Program
49.1
3749.1
38
Active Research Program
49.1
39
Active Research Program
49.1
40
NCI Comprehensive
Active Research Program
46.9
41
BC CancerVancouver, BC
29.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →